Drugs
Home Page
Xagena Medicine
Xagena.net
Epoetin alfa: reports of pure red cell aplasia and severe anemia associated with neutralizing antibodies to erythropoietin
Elderly, non-hemophiliac, intracerebral hemorrhage patients: NovoSeven increases risk of arterial thromboembolic events
Risk of birth defects with Paroxetine
Three myocardial infarctions with Vioxx were not included in VIGOR study
Europe: Revatio for the treatment of pulmonary arterial hypertension approved
Darbepoetin alfa: pure red cell aplasia and severe anemia associated with neutralizing antibodies
FDA drug prescribing warnings: physicians'compliance with the recommendations of the BBWs was highly variable
No connection between increased belly fat and decreased limb fat in men who take antiretrovirals
HMG-CoA reductase inhibitors suspected of being associated with memory loss
Antibiotics: Amoxicillin use during infancy may be linked to tooth enamel defects
Statins can reduce the incidence of major coronary events and stroke
Low-dose Acetylsalicylic acid might prevent the cardiac damage of Cox-2 inhibitors
Tarceva in association with Gemzar for advanced, inoperable or metastatic pancreatic carcinoma, FDA approved
Growth hormone illegal for off-label anti-aging use
Diabetes: Pargluva increases the risk for morbidity and mortality
Abciximab for acute ischemic stroke: patient enrollment temporarily suspended in AbESTT-II trial
FDA: Lipitor approved to reduce stroke and myocardial infarction risk in patients with type 2 diabetes
Novartis, new products portfolio
Acute decompensated CHF: concerns over Nesiritide
FDA has asked to withdraw Hydromorphone extended release for safety reasons
Black cohosh: reports of liver toxicity
Rosiglitazone reduces HDL cholesterol levels
Stevens-Johnson syndrome linked to Ibuprofen
Fentanyl transdermal patche: narcotic overdose and death
Heart Failure: Advisory Panel provides recommendations on Nesiritide
Role of nuclear receptors in inflammatory responses
Suicidality in pediatric and adult patients treated with antidepressants
iPLEDGE, a risk management program to enhance safe use of Isotretinoin for treating severe acne
Europe: Humira for the treatment of psoriatic arthritis and early rheumatoid arthritis
PCSK9 protein, a new target for cholesterol-lowering drugs
Next Pages
«
11
12
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions